Level Biotechnology Inc. (TPEX:3118)

Level Biotechnology Income Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	753.3	731.35	660.61	593.01	677.28	672.49
Revenue Growth (YoY)	5.20%	10.71%	11.40%	-12.44%	0.71%	5.26%
Cost of Revenue	495.88	494.22	441.07	390.42	444.78	460.78
Gross Profit	257.42	237.13	219.55	202.59	232.5	211.71
Selling, General & Admin	159.04	148.92	137.98	123.66	138.52	131.86
Research & Development	13.39	12.95	13.77	14.03	15.02	13.7
Operating Expenses	172.38	161.81	151.99	137.69	153.54	145.8
Operating Income	85.04	75.32	67.55	64.9	78.96	65.91
Interest Expense	-0.22	-0.28	-0.33	-0.35	-0.38	-0.43
Interest & Investment Income	3.66	5.45	5.18	2.47	1.67	1.99
Currency Exchange Gain (Loss)	0.33	-1.2	0.01	-1.17	1.65	2.27
Other Non Operating Income (Expenses)	2.26	1.82	6.14	7.21	3.12	2.71
EBT Excluding Unusual Items	91.07	81.1	78.55	73.07	85.02	72.46
Gain (Loss) on Sale of Investments	8.01	-	-	-	-	-
Gain (Loss) on Sale of Assets	-	0.02	0.1	0.08	-0.13	0.09
Pretax Income	99.08	81.13	78.65	73.16	84.89	72.54
Income Tax Expense	18.3	16.31	15.75	14.69	16.71	14.5
Net Income	80.78	64.81	62.91	58.47	68.18	58.04
Net Income to Common	80.78	64.81	62.91	58.47	68.18	58.04
Net Income Growth	23.42%	3.03%	7.59%	-14.25%	17.46%	22.46%
Shares Outstanding (Basic)	32	32	32	32	32	32
Shares Outstanding (Diluted)	33	33	33	33	33	33
Shares Change (YoY)	0.04%	-0.02%	-0.04%	0.01%	0.19%	0.03%
EPS (Basic)	2.49	2.00	1.94	1.80	2.10	1.79
EPS (Diluted)	2.48	1.99	1.93	1.79	2.09	1.78
EPS Growth	23.36%	3.11%	7.82%	-14.35%	17.42%	22.76%
Free Cash Flow	-163.67	-159.58	62.54	58.33	146.8	80.69
Free Cash Flow Per Share	-5.01	-4.89	1.92	1.79	4.49	2.48
Dividend Per Share	1.800	1.800	1.700	1.700	1.900	1.600
Dividend Growth	5.88%	5.88%	-	-10.53%	18.75%	23.08%
Gross Margin	34.17%	32.42%	33.23%	34.16%	34.33%	31.48%
Operating Margin	11.29%	10.30%	10.23%	10.95%	11.66%	9.80%
Profit Margin	10.72%	8.86%	9.52%	9.86%	10.07%	8.63%
Free Cash Flow Margin	-21.73%	-21.82%	9.47%	9.84%	21.67%	12.00%
EBITDA	101.59	91.02	83.21	80.73	95.15	83.18
EBITDA Margin	13.49%	12.45%	12.60%	13.61%	14.05%	12.37%
D&A For EBITDA	16.55	15.7	15.65	15.82	16.19	17.27
EBIT	85.04	75.32	67.55	64.9	78.96	65.91
EBIT Margin	11.29%	10.30%	10.23%	10.95%	11.66%	9.80%
Effective Tax Rate	18.47%	20.11%	20.02%	20.08%	19.69%	19.99%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.